Vortioxetine for Major Depressive Disorder in Children: 12-Week Randomized, Placebo-Controlled Study
{{output}}
Objective: To evaluate efficacy, safety, and tolerability of vortioxetine in children ages 7 to 11 years with major depressive disorder. Method: ... ...
